The Oncology Pharmacist
  • Home
  • Issues
    • 2023
      • March 2023 - Vol 16 No 2
      • January 2023 - Vol 16 No 1
    • 2022
      • November 2022 - Vol 15 No 6
      • September 2022 - Vol 15 No 5
      • July 2022 - Vol 15 No 4
      • May 2022 - Vol 15 No 3
      • March 2022 - Vol 15 No 2
      • January 2022 - Vol 15 No 1 – Online Only
    • 2021
      • November 2021 - Vol 14 No 7
      • October 2021 - Vol 14 No 6 | Biosimilars
      • September 2021 - Vol 14 No 5
      • July 2021 - Vol 14 No 4
      • May 2021 - Vol 14 No 3
      • March 2021 - Vol 14 No 2
      • January 2021 - Vol 14 No 1
    • Issue Archive
  • Special Issues
    • Supplements
      • ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
        • Checkmate 9LA
    • Guide to New FDA Approvals
      • 2019 Fourth Annual Guide
      • 2018 Third Annual Guide
      • 2017 Second Annual Guide
      • 2016 First Annual Guide
  • Categories
  • Conference Correspondent
    • ASCO 2021 Wrap-Up - Breast Cancer
  • Web Exclusives
    • Ovarian Cancer Overview
    • Interview with the Innovators
    • All Web Exclusives
    • Drug Updates
    • FDA Approvals, News & Updates
    • In the News
    • Press Releases
    • Media Library
      • Videos
      • Audiocasts
  • Quick Quiz
  • CE
  • About
    • About TOP
    • Advertise
    • Editorial Board
    • Contact Us
    • Resources
    • Author Guidelines
The Oncology Pharmacist

Corbin Davis

Authored Items
Greater Social Support May Help Alleviate Pain in Patients with Cancer
Corbin Davis
TOP - March 2020, Vol 13, No 2 in Supportive Care
Medical Cannabis in Patients with Advanced Cancer: Many Challenges Remain
Corbin Davis
TOP - January 2020, Vol 13, No 1 in Supportive Care
Cabozantinib Active as First-Line Treatment of Differentiated Thyroid Cancer
Corbin Davis
TOP - August 2018, Vol 11, No 2 in Thyroid Cancer
Low Survival in Patients with Head and Neck Cancers Linked to Delays in Radiation Therapy After Surgery
Corbin Davis
TOP - August 2018, Vol 11, No 2 in Head and Neck Cancer
Last modified: July 26, 2017
Latest Issue
 
  • Privacy Policy
  • Terms of Use
  • Home
  • About
  • Subscribe
  • Advertise
  • Contact Us

© Amplity Health. All rights reserved.
1249 South River Road - Suite 202, Cranbury, NJ 08512

  • Home
  • Issues
    • 2023
      • March 2023 - Vol 16 No 2
      • January 2023 - Vol 16 No 1
    • 2022
      • November 2022 - Vol 15 No 6
      • September 2022 - Vol 15 No 5
      • July 2022 - Vol 15 No 4
      • May 2022 - Vol 15 No 3
      • March 2022 - Vol 15 No 2
      • January 2022 - Vol 15 No 1 – Online Only
    • 2021
      • November 2021 - Vol 14 No 7
      • October 2021 - Vol 14 No 6 | Biosimilars
      • September 2021 - Vol 14 No 5
      • July 2021 - Vol 14 No 4
      • May 2021 - Vol 14 No 3
      • March 2021 - Vol 14 No 2
      • January 2021 - Vol 14 No 1
    • Issue Archive
  • Special Issues
    • Supplements
      • ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
        • Checkmate 9LA
    • Guide to New FDA Approvals
      • 2019 Fourth Annual Guide
      • 2018 Third Annual Guide
      • 2017 Second Annual Guide
      • 2016 First Annual Guide
  • Categories
  • Conference Correspondent
    • ASCO 2021 Wrap-Up - Breast Cancer
  • Web Exclusives
    • Ovarian Cancer Overview
    • Interview with the Innovators
    • All Web Exclusives
    • Drug Updates
    • FDA Approvals, News & Updates
    • In the News
    • Press Releases
    • Media Library
      • Videos
      • Audiocasts
  • Quick Quiz
  • CE
  • About
    • About TOP
    • Advertise
    • Editorial Board
    • Contact Us
    • Resources
    • Author Guidelines
Sign Up Now!

To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".

I'd like to receive: